NCT02609490

Azilsartan in Chinese Patients With Mild and Moderate Hypertension

A Multi-center, Randomized, Double-blind, Double-dummy, With Olmesartan Medoxomil as Positive Control Parallel Clinical Study to Evaluate the the Safety and Efficacy of Azilsartan in Chinese Patients With Primary Mild and Moderate Hypertension

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 304 (actual)
• Sponsor: Lee's Pharmaceutical Limited · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

A phase 3 clinical study to evaluate the safety and efficacy of Azilsartan in Chinese hypertension patients

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	Azilsartan tablets	20mg/tablet
DRUG	Azilsartan placebo tablets	placebo tablet
DRUG	Olmesartan medoxomil tablets	20mg/tablet
DRUG	olmesartan medoxomil placebo tablets	placebo tablet

Timeline

• Start date: 2015-09-01
• Primary completion: 2017-02-01
• Completion: 2018-08-01
• First posted: 2015-11-20
• Last updated: 2018-09-04

Locations

1 site across 1 country: China